These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 18303416

  • 1. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria.
    Nseir S, Ader F.
    Curr Opin Pulm Med; 2008 Mar; 14(2):95-100. PubMed ID: 18303416
    [Abstract] [Full Text] [Related]

  • 2. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S, Di Pompeo C, Cavestri B, Jozefowicz E, Nyunga M, Soubrier S, Roussel-Delvallez M, Saulnier F, Mathieu D, Durocher A.
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 4. Viral infections in patients with chronic obstructive pulmonary disease.
    Varkey JB, Varkey B.
    Curr Opin Pulm Med; 2008 Mar; 14(2):89-94. PubMed ID: 18303415
    [Abstract] [Full Text] [Related]

  • 5. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS.
    COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
    [Abstract] [Full Text] [Related]

  • 6. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease.
    Murphy TF.
    Curr Opin Infect Dis; 2006 Jun; 19(3):225-30. PubMed ID: 16645482
    [Abstract] [Full Text] [Related]

  • 7. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
    Parker CM, Kutsogiannis J, Muscedere J, Cook D, Dodek P, Day AG, Heyland DK, Canadian Critical Care Trials Group.
    J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
    [Abstract] [Full Text] [Related]

  • 8. Management of ventilator-associated pneumonia caused by multiresistant bacteria.
    Diaz E, Muñoz E, Agbaht K, Rello J.
    Curr Opin Crit Care; 2007 Feb; 13(1):45-50. PubMed ID: 17198048
    [Abstract] [Full Text] [Related]

  • 9. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
    van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C, Hendrix R.
    Clin Infect Dis; 2004 Oct 01; 39(7):980-6. PubMed ID: 15472849
    [Abstract] [Full Text] [Related]

  • 10. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
    Berim I, Sethi S.
    Ther Adv Respir Dis; 2011 Jun 01; 5(3):207-16. PubMed ID: 21378062
    [Abstract] [Full Text] [Related]

  • 11. [Bacterial flora in acute exacerbations of chronic obstructive pulmonary disease (COPD) in Kunming, China].
    Yang X, Strobel M, Tian L, Barennes H, Buisson Y.
    Med Mal Infect; 2011 Apr 01; 41(4):186-91. PubMed ID: 21195565
    [Abstract] [Full Text] [Related]

  • 12. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.
    Alamoudi OS.
    Respirology; 2007 Mar 01; 12(2):283-7. PubMed ID: 17298464
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S.
    Semin Respir Crit Care Med; 2005 Apr 01; 26(2):192-203. PubMed ID: 16088436
    [Abstract] [Full Text] [Related]

  • 14. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
    Murphy TF.
    Curr Opin Pulm Med; 2009 Mar 01; 15(2):138-42. PubMed ID: 19532029
    [Abstract] [Full Text] [Related]

  • 15. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
    Canut A, Martín-Herrero JE, Labora A, Maortua H.
    J Antimicrob Chemother; 2007 Sep 01; 60(3):605-12. PubMed ID: 17595285
    [Abstract] [Full Text] [Related]

  • 16. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
    Nseir S, Ader F, Marquette CH, Durocher A.
    Pathol Biol (Paris); 2005 Sep 01; 53(8-9):470-5. PubMed ID: 16176863
    [Abstract] [Full Text] [Related]

  • 17. Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S.
    Clin Infect Dis; 2005 Jul 15; 41 Suppl 2():S177-85. PubMed ID: 15942884
    [Abstract] [Full Text] [Related]

  • 18. Bacteria associated with acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation and antimicrobial management in Respiratory Care Unit of Central Chest Institute of Thailand.
    Siripataravanit S, Phaicharoen R, Termsetcharoen S, Klangprapun N.
    J Med Assoc Thai; 2012 Aug 15; 95 Suppl 8():S11-8. PubMed ID: 23130469
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and impact of depression in chronic obstructive pulmonary disease patients.
    Norwood R.
    Curr Opin Pulm Med; 2006 Mar 15; 12(2):113-7. PubMed ID: 16456380
    [Abstract] [Full Text] [Related]

  • 20. Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.
    Martinez FJ, Han MK, Flaherty K, Curtis J.
    Expert Rev Anti Infect Ther; 2006 Feb 15; 4(1):101-24. PubMed ID: 16441213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.